1. Soma-Pillay P, Nelson-Piercy C, Tolppanen H, et al. Physiological changes in pregnancy. Cardiovasc J Afr 2016; 27: 89-94.
2.
Chandra M, Paray AA. Natural physiological changes during pregnancy. Yale J Biol Med 2024; 97: 85-92.
3.
Ch’ng CL, Morgan M, Hainsworth I, et al. Prospective study of liver dysfunction in pregnancy in Southwest Wales. Gut 2002; 51: 876-80.
4.
Verma D, Saab AM, Saab S, et al. A systematic approach to pregnancy-specific liver disorders. Gastroenterol Hepatol 2021; 17: 322-9.
5.
Jarvis S, Nelson-Piercy C. Management of nausea and vomiting in pregnancy. BMJ 2011; 342: d3606.
6.
Dean CR, Bannigan K, Marsden J. Reviewing the effect of hyperemesis gravidarum on women’s lives and mental health. Br J Midwifery 2018; 26: 109-19.
7.
Royal College of Obstetricians and Gynecologists. The management of nausea and vomiting of pregnancy and hyperemesis gravidarum. Green-top Guideline No. 69. London: RCOG; 2016 [quote access date]. Available at: https://www.rcog.org.uk/media/y3fen1x1/gtg69-hyperemesis.pdf
8.
Liu C, Zhao G, Qiao D, et al. Emerging progress in nausea and vomiting of pregnancy and hyperemesis gravidarum: challenges and opportunities. Front Med 2022; 8: 809270.
9.
American College of Obstetricians and Gynecologists. Practice Bulletin No. 153: nausea and vomiting of pregnancy. Obstet Gynecol 2015; 126: e12-24.
10.
Popa SL, Barsan M, Caziuc A, et al. Life-threatening complications of hyperemesis gravidarum. Exp Ther Med 2021; 21: 642.
11.
Van Lieshout LCEW, Koek GH, Spaanderman MA, et al. Placenta derived factors involved in the pathogenesis of the liver in the syndrome of haemolysis, elevated liver enzymes and low platelets (HELLP): a review. Pregnancy Hypertens 2019; 18: 42-8.
12.
Haram K, Svendsen E, Abildgaard U. The HELLP syndrome: clinical issues and management. A review. BMC Pregnancy Childbirth 2009; 9: 8.
13.
Conde-Agudelo A, Romero R. SARS-CoV-2 infection during pregnancy and risk of preeclampsia: a systematic review and meta-analysis. Am J Obstet Gynecol 2022; 226: 68-89.e3.
14.
Fitzpatrick KE, Hinshaw K, Kurinczuk JJ, et al. Risk factors, management, and outcomes of hemolysis, elevated liver enzymes, and low platelets syndrome and elevated liver enzymes, low platelets syndrome. Obstet Gynecol 2014; 123: 618-27.
15.
Abildgaard U, Heimdal K. Pathogenesis of the syndrome of hemolysis, elevated liver enzymes, and low platelet count (HELLP): a review. Eur J Obstet Gynecol Reprod Biol 2013; 166: 117-23.
16.
Erez O, Othman M, Rabinovich A, et al. DIC in pregnancy - pathophysiology, clinical characteristics, diagnostic scores, and treatments. J Blood Med 2022; 13: 21-44.
17.
Sucher E, Sucher R, Gradistanac T, et al. Autoimmune hepatitis – immunologically triggered liver pathogenesis – diagnostic and therapeutic strategies. J Immunol Res 2019; 2019: 9437043.
18.
Lam M, Dierking E. Intensive care unit issues in eclampsia and HELLP syndrome. Int J Crit Illn Inj Sci 2017; 7: 136-41.
19.
Haddad B, Barton JR., Livingston JC, et al. Risk factors for adverse maternal outcomes among women with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol 2000; 183: 444-8.
20.
Chappell LC, Cluver CA, Kingdom J, et al. Pre-eclampsia. Lancet 2021; 398: 341-54.
21.
American College of Obstetricians and Gynecologists. Gestational hypertension and preeclampsia: ACOG Practice Bulletin, Number 222. Obstet Gynecol 2020; 135: e237-60.
22.
Say L, Chou D, Gemmill A, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health 2014; 2: e323-33.
23.
Uzan J, Carbonnel M, Piconne O, et al. Pre-eclampsia: pathophysiology, diagnosis, and management. Vasc Health Risk Manag 2011; 7: 467-74.
24.
National Institute for Health and Care Excellence. Hypertension in pregnancy: diagnosis and management. NICE guideline [NG133] 2019. available from: https://www.nice.org.uk/guidance/ng133. (accessed: 21.03.2021).
25.
Panther E, Blum HE. Liver disease in pregnancy [in German]. Dtsch Med Wochenscher 2008; 133: 2283-7.
26.
ACOG Committee Opinion No. 767: Emergent therapy for acute-onset, severe hypertension during pregnancy and the postpartum period. Obstet Gynecol 2019; 133: e174-80.
27.
McBride SA, Small R, Hurd K, et al. Preeclampsia and HELLP syndrome complicated by subcapsular liver hematoma and rupture. CMAJ 2023; 195: E1543-5.
28.
Floreani A, Gervasi MT. New insights on intrahepatic cholestasis of pregnancy. Clin Liver Dis 2016; 20: 177-89.
29.
Jurk SM, Kremer AE, Schleussner E. Intrahepatic cholestasis of pregnancy. Geburtshilfe Frauenheilkd 2021; 81: 940-7.
30.
Bicocca MJ, Sperling JD, Chauhan SP. Intrahepatic cholestasis of pregnancy: review of six national and regional guidelines. Eur J Obstet Gynecol Reprod Biol 2018; 231: 180-7.
31.
Davit-Spraul A, Gonzales E, Baussan C, et al. The spectrum of liver diseases related to ABCB4 gene mutations: pathophysiology and clinical aspects. Semin Liver Dis 2010; 30: 134-46.
32.
Geenes V, Chappell LC, Seed PT, et al. Association of severe intrahepatic cholestasis of pregnancy with adverse pregnancy outcomes: a prospective population-based case-control study. Hepatology 2014; 59: 1482-91.
33.
Maldonado M, Alhousseini A, Awadalla M, et al. Intrahepatic cholestasis of pregnancy leading to severe vitamin K deficiency and coagulopathy. Case Rep Obstet Gynecol 2017; 2017: 5646247.
34.
Zhang Y, Lu L, Victor DW, et al. Ursodeoxycholic acid and S-adenosylmethionine for the treatment of intrahepatic cholestasis of pregnancy: a meta-analysis. Hepat Mon 2016; 16: e38558.
35.
Ramanathan R, Ibdah JA. Mitochondrial dysfunction and acute fatty liver of pregnancy. Int J Mol Sci 2022; 23: 3595.
36.
Tan J, Hou F, Xiong H, et al. Swansea criteria score in acute fatty liver of pregnancy. Chin Med J 2022; 135: 860-2.
37.
Byrne JJ, Seasely A, Nelson DB, et al. Comparing acute fatty liver of pregnancy from hemolysis, elevated liver enzymes and low platelets syndrome. J Matern Fetal Neonatal Med 2022; 35: 1352-62.
38.
Nelson DB, Byrne JJ, Cunningham FG. Acute fatty liver of pregnancy. Obstet Gynecol 2021; 137: 535-46.
39.
Czaja AJ. Diagnosis and management of autoimmune hepatitis: current status and future directions. Gut Liver 2016; 10: 177-203.
40.
Westbrook RH, Yeoman AD, Kriese S, et al. Outcomes of pregnancy in women with autoimmune hepatitis. J Autoimmun 2012; 38: J239-44.
41.
Sun Y, Haapanen K, Li B, et al. Women and primary biliary cirrhosis. Clin Rev Allergy Immunol 2015; 48: 285-300.
42.
Melo D, Areia AL, Moura P. Primary biliary cholangitis first demonstrated in pregnancy: a case report. J Med Case Rep 2022; 16: 38.
43.
Yimam KK, Bowlus CL. Diagnosis and classification of primary sclerosing cholangitis. Autoimmun Rev 2014; 13: 445-50.
44.
Tran TT, Ahn J, Reau NS. Corrigendum: ACG Clinical Guideline: liver disease and pregnancy. Am J Gastroenterol 2016; 111: 1668.
45.
Floreani A, Infantolino C, Franceschet I, et al. Pregnancy and primary biliary cirrhosis: a case-control study. Clin Rev Allergy Immunol 2015; 48: 236-42.
46.
Liang H, Manne S, Shick J, et al. Incidence, prevalence, and natural history of primary sclerosing cholangitis in the United Kingdom. Medicine 2017; 96: e7116.
47.
Zakharia K, Tabibian A, Lindor KD, et al. Complications, symptoms, quality of life and pregnancy in cholestatic liver disease. Liver Int 2018; 38: 399-411.
48.
Wellge BE, Sterneck M, Teufel A, et al. Pregnancy in primary sclerosing cholangitis. Gut 2011; 60: 1117-21.
49.
Ferrigno B, Barba R, Medina-Morales E, et al. Cholestatic liver disease and pregnancy: a systematic review and meta-analysis. J Clin Med 2022; 11: 1068.
